DURECT Corporation
NASDAQ: DRRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- James E. Brown D.V.M.
- Employees
- 21
- Headquarters
- Cupertino, United States
- IPO year
- 2000
- Market cap
- $59.3M
- Website
- https://www.durect.com
Loading DRRX…
Loading profile data…Frequently asked questions about DRRX
What does DURECT Corporation (DRRX) do?
DURECT Corporation is a biopharmaceutical enterprise dedicated to the research and development of innovative medicines, leveraging its epigenetic regulator and pharmaceutical platforms. The company provides the ALZET product range, which includes osmotic pumps and associated accessories vital for research studies conducted on mice, rats, and oth...
Where does DRRX trade?
DURECT Corporation (DRRX) trades on the NASDAQ Capital Market.
What sector is DRRX in?
DURECT Corporation (DRRX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of DURECT Corporation?
James E. Brown D.V.M. is the chief executive officer of DURECT Corporation (DRRX).
Where is DURECT Corporation headquartered?
DURECT Corporation is headquartered in United States.
Does DRRX pay a dividend?
DURECT Corporation (DRRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DRRX go public?
DURECT Corporation (DRRX) completed its initial public offering in 2000.